Talis Biomedical's market cap is currently $50.70M. The company's EPS TTM is $-28.018; its P/E ratio is -0.06; Talis Biomedical is scheduled to report earnings on ―, and the estimated EPS forecast is $―. See an overview of income statement, balance sheet, and cash flow financials.
